Universität zu Köln

Journal Article

Al-Sawaf, Othman ORCID: 0000-0001-9895-0570, Gentile, Brittany ORCID: 0000-0002-6302-5593, Devine, Jacob, Zhang, Can, Sail, Kavita, Tandon, Maneesh, Fink, Anna-Maria, Kutsch, Nadine, Wendtner, Clemens-Martin, Eichhorst, Barbara, Hallek, Michael and Fischer, Kirsten (2021). Health-related quality of life with fixed-duration venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial. Am. J. Hematol., 96 (9). S. 1112 - 1120. HOBOKEN: WILEY. ISSN 1096-8652

Fischer, Kirsten, Fink, Anna-Maria, Bishop, Helen, Dixon, Mark, Bahlo, Jasmin, Chol, Michael Y., Weinkove, Robert ORCID: 0000-0003-3645-7988, Robinson, Sue, Dreyling, Martin, Seiler, Till, Opat, Stephen, Owen, Carolyn, Lopez, Javier, Sr., Kutsch, Nadine, Tausch, Eugen, Ritgen, Matthias, Humerickhouse, Rod A., Humphrey, Kathryn, Wenger, Michael K., Goede, Valentin, Eichhorst, Barbara, Wendtner, Clemens-Martin, Stilgenbauer, Stephan, Kipps, Thomas J. and Hallek, Michael (2015). Results of the Safety Run-in Phase of CLL14 (BO25323): A Prospective, Open-Label, Multicenter Randomized Phase Ill Trial to Compare the Efficacy and Safety of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) with Obinutuzumab and Chlorambucil in Patients with Previously Untreated CLL and Coexisting Medical Conditions. Blood, 126 (23). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Fuerstenau, Moritz, Hopfinger, Georg, Robrecht, Sandra, Fink, Anna-Maria, Al-Sawaf, Othman, Langerbeins, Petra, Cramer, Paula, Von Tresckow, Julia, Maurer, Christian, Kutsch, Nadine, Hoechstetter, Manuela, Dreyling, Martin, Lange, Elisabeth, Kneba, Michael, Stilgenbauer, Stephan, Doehner, Hartmut, Hensel, Manfred, Kiehl, Michael G., Jaeger, Ulrich, Wendtner, Clemens-Martin, Goede, Valentin, Fischer, Kirsten, von Bergwelt-Baildon, Michael, Eichhorst, Barbara, Hallek, Michael and Theurich, Sebastian ORCID: 0000-0001-5706-8258 (2020). Influence of obesity and gender on treatment outcomes in patients with chronic lymphocytic leukemia (CLL) undergoing rituximab-based chemoimmunotherapy. Leukemia, 34 (4). S. 1177 - 1182. LONDON: SPRINGERNATURE. ISSN 1476-5551

Goedel, Philipp, Sieg, Noelle, Heger, Jan-Michel, Kutsch, Nadine, Herling, Carmen, Baermann, Ben-Niklas, Scheid, Christof, Borchmann, Peter and Holtick, Udo (2021). Hematologic Rescue of CAR T-cell-mediated Prolonged Pancytopenia Using Autologous Peripheral Blood Hematopoietic Stem Cells in a Lymphoma Patient. Hemasphere, 5 (3). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Heger, Jan-Michel, Mattlener, Julia, Godel, Philipp, Balke-Want, Hyatt, Sieg, Noelle, Kutsch, Nadine, Becker, Kerstin, Weiss, Jonathan, Reinhardt, H. Christian, Hallek, Michael, Borchmann, Peter, von Tresckow, Bastian and Borchmann, Sven (2022). Noninvasive, Dynamic Risk Profiling of Primary Central Nervous System Lymphoma By Peripheral Blood Ctdna-Sequencing. Blood, 140. S. 3537 - 3539. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kaddu-Mulindwa, Dominic ORCID: 0000-0001-8832-252X, Godel, Philipp, Kutsch, Nadine, Heger, Jan-Michel ORCID: 0000-0001-9463-8504, Scheid, Christof, Borchmann, Peter, Holtick, Udo, Held, Gerhard, Thurner, Lorenz, Bewarder, Moritz, Rixecker, Torben and Bittenbring, Joerg-Thomas (2022). Salvage High-dose Melphalan With Autologous Stem cell Transplantation as Bridge to Consolidation Therapy for Chemoresistant Aggressive B-cell Lymphoma. Clin. Lymphoma Myeloma Leuk., 22 (7). S. E498 - 9. DALLAS: CIG MEDIA GROUP, LP. ISSN 2152-2669

Kutsch, Nadine (2021). CLL-IPI: valid in the era of oral inhibitors? Blood, 138 (2). S. 106 - 108. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kutsch, Nadine, Bahlo, Jasmin, Bergmann, Manuela, Byrd, John, Doehner, Hartmut, Eichhorst, Barbara, Else, Monica, Geisler, Christian, Grever, Michael, Lepretre, Stephane, Neuberg, Donna, Oscier, David, Rosenquist, Richard, Robak, Tadeusz, Shanafelt, Tait, Stilgenbauer, Stephan and Hallek, Michael (2015). The international prognostic index for patients with CLL(CLL-IPI) - an international meta-analysis. Leuk. Lymphoma, 56. S. 127 - 128. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Kutsch, Nadine, Bahlo, Jasmin, Robrecht, Sandra, Franklin, Jeremy, Zhang, Can, Maurer, Christian, De Silva, Nisha, Lange, Elisabeth, Weide, Rudolf, Kiehl, Michael G., Soekler, Martin, Schlag, Rudolf, Vehling-Kaiser, Ursula, Koechling, Georg, Ploeger, Christoph, Gregor, Michael, Plesner, Torben, Herling, Marco, Fischer, Kirsten, Doehner, Hartmut, Kneba, Michael, Wendtner, Clemens-Martin, Klapper, Wolfram, Kreuzer, Karl-Anton, Boettcher, Sebastian, Stilgenbauer, Stephan, Fink, Anna Maria, Hallek, Michael and Eichhorst, Barbara (2020). Long Term Follow-up Data and Health-Related Quality of Life in Frontline Therapy of Fit Patients Treated With FCR Versus BR (CLL10 Trial of the GCLLSG). Hemasphere, 4 (1). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Kutsch, Nadine, Fink, Anna Maria, Federhen, Anno, Giza, Adam, Robrecht, Sandra, Stumpf, Janina, Stoltefuss, Andrea, Vehling-Kaiser, Ursula, Koenigsmann, Michael, Tausch, Eugen, Schneider, Christof, Stilgenbauer, Stephan, Illmer, Thomas, Schlag, Rudolf, Doerfel, Steffen, Gaska, Tobias, Kiehl, Michael G., Fischer, Kirsten, Eichhorst, Barbara and Hallek, Michael (2022). Fludarabine, Cyclophosphamide and Rituximab (FCR) As First Line Treatment in Patients with Chronic Lymphocytic Leukemia (CLL): A Long-Term Analysis of the German CLL Study Group (GCLLSG) Registry. Blood, 140. S. 9879 - 9882. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kutsch, Nadine, Fink, Anna Maria and Fischer, Kirsten (2022). Management of front line chronic lymphocytic leukemia. Am. J. Hematol., 97. S. S3 - 8. HOBOKEN: WILEY. ISSN 1096-8652

Kutsch, Nadine, Goedel, Philipp, Holtick, Udo, Lohneis, Anja, Vucinic, Vladan, Altefrohne, Florentine Pia, Schubert, Christin, Karitzky, Sandra, Hanssens, Linda, Assenmacher, Mario, Buerger, Iris, Aktas, Murat and Borchmann, Peter (2022). A Phase I Dose Finding Trial of MB-CART20.1 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma. Blood, 140. S. 12980 - 12982. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Kutsch, Nadine, Goedel, Philipp, Voltin, Conrad-Amadeus, Kobe, Carsten, Hallek, Michael ORCID: 0000-0002-7425-4455, Scheid, Christof, Borchmann, Peter and Holtick, Udo (2022). Sustained Remission of Relapsed Diffuse Large B-cell Lymphoma After Safe Administration of CD19-directed CAR T-cells in a Patient With Chronic Intestinal and Pulmonal GvHD. Hemasphere, 6 (7). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Kutsch, Nadine, Hallek, Michael and Eichhorst, Barbara (2015). Emerging therapies for refractory chronic lymphocytic leukemia. Leuk. Lymphoma, 56 (2). S. 285 - 293. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Kutsch, Nadine, Holmes, Emily Eva, Robrecht, Sandra, Schueler, Gudrun, Vehling-Kaiser, Ursula, Decker, Thomas, Mueller-Hagen, Sigrun, Heinisch, Karin, Boettcher, Sebastian, Ritgen, Matthias, Kreuzer, Karl-Anton, Stilgenbauer, Stephan, Fink, Anna Maria, Fischer, Kirsten, Eichhorst, Barbara, Hallek, Michael and Wendtner, Clemens-Martin (2023). Efficacy and safety of obinutuzumab combined with fludarabine and cyclophosphamide (FCG) or bendamustine (BG) in relapsed or refractory CLL patients followed by maintenance therapy with obinutuzumab for responding patients. Leuk. Lymphoma, 64 (2). S. 478 - 483. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403

Kutsch, Nadine, Marks, Reinhard, Ratei, Richard, Held, Thomas K. and Schmidt-Hieber, Martin (2015). Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms. Biomark. Insights, 10. S. 15 - 24. LONDON: SAGE PUBLICATIONS LTD. ISSN 1177-2719

Kutsch, Nadine, Pallasch, Christian, Decker, Thomas ORCID: 0000-0003-3814-8775, Hebart, Holger, Chow, Kai Uwe, Graeven, Ullrich, Kisro, Jens, Kroeber, Alexander, Tausch, Eugen, Fischer, Kirsten, Fink, Anna-Maria, Wendtner, Clemens-Martin, Ritgen, Matthias, Stilgenbauer, Stephan, Zhang, Danjie, Li, Biao, Jurgensmeier, Juliane M., Rajakumaraswamy, Nishanthan, Bhargava, Pankaj, Hallek, Michael ORCID: 0000-0002-7425-4455 and Eichhorst, Barbara (2022). Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. Hemasphere, 6 (6). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Kutsch, Nadine, Pallasch, Christian, Tausch, Eugen, Boehme, Volkmar, Ritgen, Matthias, Liersch, Ruediger, Wacker, Alexander, Jacobs, Georg, Trappe, Ralf Ulrich ORCID: 0000-0001-7565-7160, Dreger, Peter, Fischer, Kirsten, Fink, Anna-Maria, Stilgenbauer, Stephan, Zhai, Shuyan, Li, Biao, Jurgensmeier, Juliane M., Rajakumaraswamy, Nishanthan, Bhargava, Pankaj, Hallek, Michael ORCID: 0000-0002-7425-4455 and Eichhorst, Barbara F. (2022). Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. Hemasphere, 6 (4). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 2572-9241

Pallasch, Christian P., Ilya, Leskov, Soto, Yadira M., Braun, Christian J., Kutsch, Nadine, Drake, Adam, Frenzel, Lukas P., Iliopoulou, Bettina, van Rooijen, Nico, Wendtner, Clemens, Hallek, Michael, Chen, Jianzhu and Hemann, Michael T. (2012). Drug-Induced Cytokine Release Sensitizes Protective Tumor Microenvironments to Antibody-Mediated Therapy. Blood, 120 (21). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 0006-4971

Pallasch, Christian P. ORCID: 0000-0001-5675-6905, Leskov, Ilya, Braun, Christian J., Vorholt, Daniela, Drake, Adam, Soto-Feliciano, Yadira M., Bent, Eric H., Schwamb, Janine, Iliopoulou, Bettina, Kutsch, Nadine, van Rooijen, Nico, Frenzel, Lukas P., Wendtner, Clemens M., Heukamp, Lukas ORCID: 0000-0002-3388-3482, Kreuzer, Karl Anton, Hallek, Michael, Chen, Jianzhu and Hemann, Michael T. (2014). Sensitizing Protective Tumor Microenvironments to Antibody-Mediated Therapy. Cell, 156 (3). S. 590 - 603. CAMBRIDGE: CELL PRESS. ISSN 1097-4172